4
Tetrahedron
Acknowledgments
F3C
N
F3C
N
F3C
HCl
(3 M)
H2 (1 atm)
Pd/C
O
OH
OH
OH
OH
O
O
A part of this research is financially supported by the Grant-
in-Aid for Young Scientists (B) 21750137 (MEXT, Japan). The
generous allotment of computational time from the Institute for
Molecular Science (Okazaki, Japan) is gratefully acknowledged.
O
O
H2N
O
water/iPrOH
MeOH
rt
97 %
O
O
O
rt
Ph
Ph
(2R,3S)-6a
Ph
Ph
(2R,3S)-7a
91%
(2R,3S)-
4,4,4-Trifluoro-
allo-Thr
Supplementary Data
Scheme 4. Deprotection of (2R,3S)-6a to form (2R,3S)-4,4,4-
trifluoro-allo-threonine.
Supplementary data associated with this article can be found,
.
the six-membered ring of the (2S,3S)-isomer, the oxazolidinone
and trifluoromethyl substituents are arranged near to each other
(Figure 1b, lower) to cause a sterically congested and unstable
structure, compared with the (2R,3S)-isomer. This stability order
is in good agreement with that of the trans and cis isomers of
general cyclic compounds. The calculated ∆G value of 4.5 kcal
mol–1 corresponds to the isomer ratio of 99.95:0.05 and can
elucidate the observed high stereoselectivity in Step-II.
References and notes
1. (a) Yoder, N. C.; Kumar, K. Chem. Soc. Rev. 2002, 31, 335–341;
(b) Bégué, J. -P.; Bonnet-Delpon, D. J. Fluorine Chem. 2006, 127,
992–1012; (c) Müller, K.; Faeh, C.; Diederich, F. Science 2007,
317, 1881–1886; (d) Filler, R.; Saha, R. Future Med. Chem. 2009,
1, 777–791; (e) Fluorine in Medicinal Chemistry and Chemical
Biology; Ojima, I., Ed.; Wiley-Blackwell: Chichester, 2009; (f)
Salwiczek, M.; Nyakatura, E. K.; Gerling, U. I. M.; Ye, S.;
Koksch, B. Chem. Soc. Rev. 2012, 41, 2135–2171.
As we envisioned, two-stage deprotection of (2R,3S)-6a
proceeded smoothly without losing diastereopurity to afford
(2R,3S)-4,4,4-trifluoro-allo-threonine (Scheme 4). In the first
stage, the acetal moiety of (2R,3S)-6a was removed by acid
2. (a) Sutherland, A.; Willis, C. L. Nat. Prod. Rep. 2000, 17, 621–
631; (b) Qiu, X. L.; Qing, F. L. Eur. J. Org. Chem. 2011, 3261−
3278; (c) Aceña, J. L.; Sorochinsky, A. E.; Moriwaki, H.; Sato, T.;
Soloshonok, V. A. J. Fluorine Chem. 2013, 155, 21–38.
3. (a) Schlosser, M. Angew. Chem. Int. Ed. 1998, 37, 1496–1513; (b)
O’Hagan, D. Chem. Soc. Rev. 2008, 37, 308–319.
4. (a) Kitamoto, T.; Marubayashi, S.; Yamazaki, T. Chem. Lett.
2006, 35, 1264–1265; (b) Kitamoto, T.; Marubayashi, S.;
Yamazaki, T. Tetrahedron 2008, 64, 1888–1894.
5. (a) Guanti, G.; Banfi, L.; Narisano, E. Tetrahedron 1988, 44,
5553–5562; (b) Von dem Bussche-Hunnefeld, C.; Seebach, D.
Chem. Ber. 1992, 125, 1273–1281; (c) Sting, A. R.; Seebach, D.
Tetrahedron 1996, 52, 279–290.
6. Jiang, Z. X.; Qin, Y. Y.; Qing, F. L. J. Org. Chem. 2003, 68,
7544–7547.
7. (a) Seebach, D.; Juaristi, E.; Miller, D. D.; Schickli, C.; Weber, T.
Helv. Chim. Acta 1987, 70, 237–261; (b) Soloshonok, V. A.;
Kukhar, V. P.; Galushko, S. V.; Svistunova, N. Y.; Avilov, D. V.;
Kuzmina, N. A.; Raevski, N. I.; Struchkov, Y. T.; Pysarevsky, A.
P.; Belokon, Y. N. J. Chem. Soc. Perkin Trans. 1 1993, 3143–
3155.
8. Zard, S. Z. Org. Biomol. Chem. 2007, 5, 205–213.
9. (a) Boivin, J.; El Kaim, L.; Zard, S. Z. Tetrahedron Lett. 1992, 33,
1285–1288; (b) Boivin, J.; El Kaim, L.; Zard, S. Z. Tetrahedron
1995, 51, 2573–2584; (c) Boivin, J.; El Kaim, L.; Zard, S. Z.
Tetrahedron 1995, 51, 2585–2592.
1
treatment to give (2R,3S)-7a in 91% yield. Because the H and
19F NMR spectra of the product showed one set of signals, we
concluded that the stereochemistry at the C(2) and C(3) positions
of the product was preserved through the acid treatment
(Supplementary Figure S5). Otherwise, the product must be a
mixture of multiple diastereoisomers, owing to the presence of
chiral oxazolidinone unit, and would give multiple sets of NMR
signals. Although the stereochemical stability at the C(2)
position of (2R,3S)-7a was quite unlike to the above-described
nature of its precursor (2R,3S)-6a, of which the C(2) proton can
exchange with solvent protons at ambient conditions
(Supplementary Figure S4), this is most likely because the
scission of the cyclic structure in (2R,3S)-6a released the
structural constraint and reduced the acidity of the C(2) proton.
In the next stage, the oxazolidinone unit of (2R,3S)-7a was
cleaved by catalytic hydrogenolysis to give the target (2R,3S)-
1
4,4,4-trifluoro-allo-threonine in 97% yield (Scheme 4). The H
and 19F NMR spectra of the product again showed one set of
signals, thereby excluding the formation of the diastereoisomers
(Supplementary Figure S6). Furthermore, the specific rotation of
26
the product ([α]D = 11.6 deg cm2 g–1, (c 0.4, H2O)) is in good
10. Ager, D. J.; Prakash, I.; Schaad, D. R. Chem. Rev. 1996, 96, 835–
875.
agreement with those reported,6 indicating that the
stereochemistry at the C(2) and C(3) positions of the product was
preserved through the hydrogenolysis.
11. (a) Saigo, K.; Kasahara, A.; Ogawa, S.; Nohira, H. Tetrahedron
Lett. 1983, 24, 511–512; (b) Hashimoto, Y.; Takaoki, K.; Sudo,
A.; Ogasawara, T.; Saigo, K. Chem. Lett. 1995, 235–236; (c)
Kagoshima, H.; Hashimoto, Y.; Oguro, D.; Saigo, K. J. Org.
Chem. 1998, 63, 691–697; (d) Matsui, S.; Hashimoto, Y.; Saigo,
K. Synthesis 1998, 1161–1166.
12. The minor isomer [(2S,3R)-6a] afforded large single crystals,
which allowed for the determination of its stereochemistry by X-
ray crystallography. On the other hand, the major isomer
[(2R,3S)-6a] was of low crystallinity. Therefore, (2R,3S)-6a was
In conclusion, we developed a highly practical and efficient
method to prepare enantiopure (2R,3S)-4,4,4-trifluoro-allo-
threonine (7 steps, 51% overall yield), using an easily available
fluorinated building block and a chiral auxiliary. Trifluoroacetic
anhydride is one of the most ideal fluorinated building blocks, in
terms of cost, safety, and handling. Because all reactions
proceeded in high yields without using expensive/toxic materials
and special facilities/techniques, the present method is
advantageous for large-scale synthesis. Moreover, this method is
certainly applicable for the preparation of (2S,3R)-4,4,4-trifluoro-
allo-threonine, because both enantiomers of the starting material,
erythro-2-amino-1,2-diphenylethanol, for the chiral auxiliary are
commercially available. Considering the possibility of further
asymmetric transformation of the key intermediates 5a–c, such as
the 1,4-addition to the α,β-unsaturated carbonyl unit using
various nucleophiles, the present method would lead to the large-
scale stereocontrolled preparation of other fluorinated α-amino
acids.
converted into a more crystalline derivative [(2R,3S)-8a; see
Supplementary Data], and its stereochemistry was determined by
X-ray crystallography.
13. CCDC-1012850 [(2R,3S)-8a] and CCDC-1012851 [(2S,3R)-6a]
contain the supplementary crystallographic data for this paper.
These data can be obtained free of charge from the Cambridge
Crystallographic
Data
Centre
via
14. Through the hydride reduction of 5b and 5c, two kinds of products
were exclusively obtained at ratios of 99:1 and 97:3. Judging
from the 1H NMR coupling constants between C(2)H and C(3)H
in their lactone unit (~10 Hz), these products are deduced to be the
trans isomers. Considering the analogy to 5a, the major and